Nuveen Asset Management, LLC Vir Biotechnology, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 521,863 shares of VIR stock, worth $3.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

521,863

Previous 216,210 141.37%

Holding current value

$3.86 Million

Previous $1.92 Million 103.12%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.26 - $10.7 $2.22 Million - $3.27 Million	305,653 Added 141.37%	521,863 $3.91 Million
Q2 2024 Aug 09, 2024	BUY	$7.63 - $12.66 $60,353 - $100,140	7,910 Added 3.8%	216,210 $1.92 Million
Q4 2023 Feb 14, 2024	BUY	$7.76 - $10.29 $22,829 - $30,273	2,942 Added 1.43%	208,300 $2.1 Million
Q3 2023 Nov 14, 2023	SELL	$9.14 - $24.62 $12,594 - $33,926	-1,378 Reduced 0.67%	205,358 $1.92 Million
Q2 2023 Aug 14, 2023	SELL	$23.2 - $27.29 $2.35 Million - $2.76 Million	-101,187 Reduced 32.86%	206,736 $5.07 Million
Q1 2023 May 15, 2023	SELL	$22.26 - $30.85 $4.14 Million - $5.73 Million	-185,799 Reduced 37.63%	307,923 $7.17 Million
Q4 2022 Feb 14, 2023	SELL	$19.96 - $28.22 $1.45 Million - $2.05 Million	-72,659 Reduced 12.83%	493,722 $12.5 Million
Q3 2022 Nov 14, 2022	SELL	$18.26 - $31.1 $1.82 Million - $3.11 Million	-99,846 Reduced 14.99%	566,381 $10.9 Million
Q2 2022 Aug 15, 2022	SELL	$19.08 - $26.7 $2.37 Million - $3.32 Million	-124,437 Reduced 15.74%	666,227 $17 Million
Q1 2022 May 16, 2022	BUY	$21.19 - $40.01 $3.61 Million - $6.83 Million	170,599 Added 27.51%	790,664 $20 Million
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $8.84 Million - $15.4 Million	285,300 Added 85.22%	620,065 $26 Million
Q3 2021 Nov 12, 2021	BUY	$34.9 - $54.54 $3.44 Million - $5.37 Million	98,520 Added 41.7%	334,765 $14.6 Million
Q2 2021 Aug 16, 2021	BUY	$38.75 - $51.0 $198,322 - $261,018	5,118 Added 2.21%	236,245 $11.2 Million
Q1 2021 May 17, 2021	SELL	$26.34 - $83.07 $74,120 - $233,758	-2,814 Reduced 1.2%	231,127 $11.9 Million
Q4 2020 Feb 16, 2021	SELL	$25.51 - $43.38 $2.44 Million - $4.15 Million	-95,707 Reduced 29.03%	233,941 $6.27 Million
Q3 2020 Nov 16, 2020	BUY	$28.28 - $53.6 $2.91 Million - $5.52 Million	102,971 Added 45.43%	329,648 $11.3 Million
Q2 2020 Aug 14, 2020	BUY	$27.89 - $47.86 $5.3 Million - $9.09 Million	189,973 Added 517.58%	226,677 $9.29 Million
Q1 2020 May 14, 2020	BUY	$12.04 - $60.2 $305,382 - $1.53 Million	25,364 Added 223.67%	36,704 $1.26 Million
Q4 2019 Feb 14, 2020	BUY	$11.83 - $15.85 $134,152 - $179,739	11,340 New	11,340 $143,000

Others Institutions Holding VIR

# of Institutions

218

Shares Held

87M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Vir Biotechnology, Inc. Transaction History